Kerry M. Clem
Chief Commercial Officer, Acorda Therapeutics.
Companies
- Acorda TherapeuticsChief Commercial Officer Sep 20, 2021 to Apr 4, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Acorda Therapeutics ACOR10,083 shares2Sep 3, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 3, 2022Shares withheld for tax 1,511 shares at $0.40 of Acorda Therapeutics2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2